Anna Sivula
Impact in
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
Papers in
-
- Inflammatory mediators and NSAID effects 6
- Genetics 4
- Estrogen and related hormone effects 4
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 1
- Co-authors
- Caj Haglund (7 shared papers)Ari Ristimäki (7 shared papers)Heikki Joensuu (2 shared papers)Johan Lundin (2 shared papers)Mikael Lundin (1 shared paper)Jorma Isola (1 shared paper)Tiina Salminen (1 shared paper)G. Johan A. Offerhaus (4 shared papers)
- Journals
- International Journal of Cancer (2 papers)Apmis (1 paper)Gastroenterology (1 paper)Breast Cancer Research and Treatment (1 paper)Gynecologic Oncology (1 paper)
- Partner nations
- FinlandNetherlandsUnited States
In The Last Decade
Anna Sivula
9 papers receiving 1.3k citations
Anna Sivula's Hit Papers
Peers
Comparison fields: 5 of 71
- Pharmacology 654
- Cancer Research 215
- Genetics 352
- Psychiatry and Mental health 159
- Oncology 207
Countries citing papers authored by Anna Sivula
This map shows the geographic impact of Anna Sivula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Sivula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Sivula more than expected).
Fields of papers citing papers by Anna Sivula
This network shows the impact of papers produced by Anna Sivula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Sivula. The network helps show where Anna Sivula may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Sivula, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Hit paper breakdown → | 2002 | 672 |
| 2 | 2002 | 183 | |
| 3 | Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. | 2003 | 132 |
| 4 | 2003 | 100 | |
| 5 | 2005 | 79 | |
| 6 | 2003 | 70 | |
| 7 | 2005 | 29 | |
| 8 | 2005 | 17 | |
| 9 | 2022 | 1 |
About Anna Sivula
Anna Sivula is a scholar working on Pharmacology, Genetics, Surgery, Molecular Biology and Genetics, having authored 9 papers that have together received 1.3k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (6 papers), Estrogen and related hormone effects (4 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Steroid Chemistry and Biochemistry (1 paper), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper), Cancer-related gene regulation (1 paper), Cultural Industries and Urban Development (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Pharmacology (654 citations), Cancer Research (215 citations), Genetics (352 citations), Psychiatry and Mental health (159 citations) and Oncology (207 citations). Anna Sivula has collaborated with scholars based in Finland, Netherlands and United States. Frequent co-authors include Caj Haglund, Ari Ristimäki, Heikki Joensuu, Johan Lundin, Mikael Lundin, Jorma Isola, Tiina Salminen, G. Johan A. Offerhaus, Bastiaan P. van Rees and J. Jan B. van Lanschot. Their work appears in journals such as International Journal of Cancer, Apmis, Gastroenterology, Breast Cancer Research and Treatment and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.